Business Case: Investing in Production of High-Quality Misoprostol for Low-Resource Settings

Download File

Abstract

In this business case, Jhpiego proposes a market shaping strategy to improve the availability of quality misoprostol products. The strategy suggests that international partners work with national procurement agencies to improve procurement guidelines and procedures to ensure that only quality drugs are accepted into the countries. Partners can help countries review their EMLs to ensure that misoprostol is approved for the prevention and treatment of PPH. International partners can also work with National Drug Regulatory Agencies (NDRAs) and others to increase awareness about quality issues with misoprostol. With stricter enforcement of national guidelines, and routine quality audits of drugs in the country, procurers will ensure the drugs they procure are quality assured. Procurers will be encouraged to procure WHO-prequalified drugs or those approved by other SRAs.